ZEB1 deficient pancreatic cancer cell lines are incapable of compensatory increasing glycolysis when oxidative phosphorylation is blocked, highlighting poor glycolytic reserve (Krebs et al, 2017). This evidence concerns the gene ZEB1 and pancreatic neoplasm.